oleyl oleate: RN given refers to (Z)-isomer
oleyl oleate : A wax ester obtained by the formal condensation of oleic acid and oleyl alcohol.
ID Source | ID |
---|---|
PubMed CID | 5364672 |
CHEBI ID | 75626 |
SCHEMBL ID | 43555 |
MeSH ID | M0182557 |
Synonym |
---|
9-octadecenoic acid (z)-, 9-octadecenyl ester, (z)- |
oleyl oleate, >=99% |
oleyl oleate |
A38B6197-BFDC-456E-9034-95819F5FDA09 |
cis 9,10 octadecenyl cis 9,10 octadecanoate |
3687-45-4 |
D09361 |
oleyl oleate (nf) |
[(z)-octadec-9-enyl] (z)-octadec-9-enoate |
LMFA07010153 |
9z-octadecenyl 9z-octadecenoate |
we(18:1(9z)/18:1(9z)) |
(9z)-octadec-9-en-1-yl (9z)-octadec-9-enoate |
CHEBI:75626 |
octadecen-1-ol oleate ester |
1-o-(9z)-octadecenyl (9z)-octadecenoate |
9-octadecenoic acid (9z)-, (9z)-9-octadecen-1-yl ester |
9-octadecenoic acid, 9-octadecenyl ester |
9-octadecenoic acid (9z)-, (9z)-9-octadecenyl ester |
oleyl oleate [nf] |
ec 222-980-0 |
unii-3x3l452y85 |
(z)-octadec-9-enyl oleate |
3x3l452y85 , |
einecs 222-980-0 |
oleic acid oleyl ester |
oleic acid, cis-9-octadecenyl ester |
crodamol oo-v |
oleyl oleate [ii] |
cosmol liquid |
oleyl oleate [inci] |
oleyl oleate [mart.] |
oleyl oleate [usp-rs] |
9-octadecen-1-ol, oleate, (z)- |
exceparl ol-ol |
schercemol olo |
cetiol |
SCHEMBL43555 |
W-106583 |
wickenol 143 |
oleic acid, (z)-9-octadecenyl ester |
schercemol olo ester |
(9z)-9-octadecenyl (9z)-9-octadecenoate |
mfcd00072252 |
oleyl oleate, united states pharmacopeia (usp) reference standard |
(9z)-9-octadecen-1-yl (9z)-9-octadecenoate |
DTXSID20893537 |
Q27145429 |
methyl6-bromo-2-chloroquinoline-4-carboxylate |
CS-0185696 |
HY-W127466 |
Class | Description |
---|---|
wax ester | A fatty acid ester resulting from the condensation of the carboxy group of a fatty acid with the alcoholic hydroxy group of a fatty alcohol. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (36.38) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |